Literature DB >> 23920148

Conservatively managed fetal goiter: an alternative to in utero therapy.

Yair J Blumenfeld1, Alexis Davis, Kristina Milan, Jane Chueh, Louanne Hudgins, Richard A Barth, Susan R Hintz.   

Abstract

Fetal goiter may arise from a variety of etiologies including iodine deficiency, overtreatment of maternal Graves' disease, inappropriate maternal thyroid replacement and, rarely, congenital hypothyroidism. Fetal goiter is often associated with a retroflexed neck and polyhydramnios, raising concerns regarding airway obstruction in such cases. Prior reports have advocated for cordocentesis and intra-amniotic thyroid hormone therapy in order to confirm the diagnosis of fetal thyroid dysfunction, reduce the size of the fetal goiter, reduce polyhydramnios, aid with the assistance of maternal thyroid hormone therapy and reduce fetal malpresentation. We report two cases of conservatively managed fetal goiter, one resulting in a vaginal delivery, and no evidence of postnatal respiratory distress despite the presence of polyhydramnios and a retroflexed neck on prenatal ultrasound.

Entities:  

Mesh:

Year:  2013        PMID: 23920148     DOI: 10.1159/000353387

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  2 in total

1.  Neonatal Dyshormonogenetic Goiter with Hypothyroidism Associated with Novel Mutations in Thyroglobulin and SLC26A4 Gene.

Authors:  Valeria Calcaterra; Rossella Lamberti; Claudia Viggiano; Sara Gatto; Luigina Spaccini; Gianluca Lista; Gianvincenzo Zuccotti
Journal:  Pediatr Rep       Date:  2021-05-02

2.  Case Report: Functional Analysis and Neuropsychological Evaluation of Dyshormonogenetic Fetal Goiter in Siblings Caused by Novel Compound Hyterozygous TPO Gene Mutations.

Authors:  Tania Maria Barreto Rodrigues; Marlon Messias da Conceição Silva; Magali Maciel Freitas; Zélia Maria Costa Duarte; Vitória Sousa Frutuoso; Mariana Teixeira Rodrigues; Ileana Gabriela Sanchez Rubio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.